SERPINB5 and breast cancer: The results of these studies are conflicting, three studies suggested that maspin underexpression could be a potential poor prognostic marker in breast cancer, while the fourth identified maspin overexpression rather as an independent poor prognostic indicator in breast cancer patients (Umerika et al, 2002).